Vetter Pharma International GmbH
Filling your clinical development needs Vetter Development Service provides expert support for your drug development projects, from inception to market launch. Our services include state-of-the-art clinical manufacturing at our facilities in Chicago and Europe, with scale-up and transfer to our large-scale manufacturing facilities. Thanks to the latest technology and innovative processes, we help increase your API yield.
Vetter Development Service provides:
• Formulation support
• Process development
• Clinical trial manufacturing
• Analytical service
• Regulatory support
Learn more (please link this)
www.vetter-pharma.com/en/services/development-service?utm_source=pte&utm_medium=text-ad&utm_content=vds&utm_campaign=products-services
Contact Details:
For US inquiries please contact +1-847-581-6888 or infoUS@vetter-pharma.com.
For Asia Pacific inquiries please contact +65-6808-7766 or infoAsiaPacific@vetter-pharma.com.
For EU and other international inquiries please contact +49-751-3700-0 or info@vetter-pharma.com.
Visit www.vetter-pharma.comfor more information
Company Details:
Company name: Vetter Pharma International GmbH
Website: www.vetter-pharma.com
E-mail: info@vetter-pharma.com
Stand/Booth number: (4.1K70)
Transformations in Drug Development for Cell and Gene Therapies
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
Advancing Clinical Trials with Spectral Flow Cytometry: A Conversation with Kevin Lang
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
Pharmaceutical Tariffs Are Imminent: How Industry is Bracing for Impact
April 16th 2025On April 14, 2025, the Trump Administration launched a national security-driven investigation into pharmaceuticals, a move that will likely result in tariffs being placed on pharmaceutical drugs, ingredients, and other components that are imported from outside of the United States.
